Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia

Baseline putamen volume as a predictor of positive symptom reduction in patients at clinical high risk for psychosis: A preliminary study

(2015) Sang Bin Hong et al.   SCHIZOPHRENIA RESEARCH

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task

(2013) Ivonne Suridjan et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Imaging Nicotine- and Amphetamine-Induced Dopamine Release in Rhesus Monkeys with [11C]PHNO vs [11C]raclopride PET

(2013) Jean-Dominique Gallezot et al.   NEUROPSYCHOPHARMACOLOGY

Are dopamine D2 receptors out of control in psychosis?

(2013) Philip Seeman   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Test-retest reproducibility of dopamine D2/3 receptor binding in human brain measured by PET with [11C]MNPA and [11C]raclopride

(2012) Fumitoshi Kodaka et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers

(2012) Amira K. Brown et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia

(2012) R.S. Wallwork et al.   SCHIZOPHRENIA RESEARCH

Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans

(2011) Paul Shotbolt et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia

(2010) Magdalena Nord et al.   CNS Neuroscience & Therapeutics

All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors

(2010) Philip Seeman   CNS Neuroscience & Therapeutics

Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy

(2010) Andri C. Tziortzi et al.   NEUROIMAGE

Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults

(2009) Susan E. Hardy   American Journal Geriatric Pharmacotherapy

A probabilistic MR atlas of the human cerebellum

(2009) Jörn Diedrichsen et al.   NEUROIMAGE

Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen

(2009) Serge A. Mitelman et al.   SCHIZOPHRENIA RESEARCH

Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2and D3dopamine receptors

(2009) Mette Skinbjerg et al.   SYNAPSE

The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study

(2008) Ariel Graff-Guerrero et al.   NEUROPSYCHOPHARMACOLOGY

Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2Highreceptors and marked supersensitivity to the dopamine agonist (+)PHNO

(2008) Philip Seeman et al.   SYNAPSE

Dopamine D2Highreceptors measured ex vivo are elevated in amphetamine-sensitized animals

(2008) Philip Seeman   SYNAPSE